The global market for Infectious Respiratory Disease Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Infectious Respiratory Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Respiratory Disease Diagnostics.

The Infectious Respiratory Disease Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Respiratory Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Respiratory Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Infectious Respiratory Disease Diagnostics Market Report

Report Metric	Details
Report Name	Infectious Respiratory Disease Diagnostics Market
CAGR	5%
Segment by Type	Instruments Consumables Services
Segment by Application	COVID-19 Influenza Respiratory Syncytial Virus (RSV) Tuberculosis Streptococcus Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., BioMerieux SA, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Respiratory Disease Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Respiratory Disease Diagnostics Market report?

Ans: The main players in the Infectious Respiratory Disease Diagnostics Market are Abbott, Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., BioMerieux SA, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen

What are the Application segmentation covered in the Infectious Respiratory Disease Diagnostics Market report?

Ans: The Applications covered in the Infectious Respiratory Disease Diagnostics Market report are COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing

What are the Type segmentation covered in the Infectious Respiratory Disease Diagnostics Market report?

Ans: The Types covered in the Infectious Respiratory Disease Diagnostics Market report are Instruments, Consumables, Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Instruments

1.2.3 Consumables

1.2.4 Services

1.3 Market by Application

1.3.1 Global Infectious Respiratory Disease Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 COVID-19

1.3.3 Influenza

1.3.4 Respiratory Syncytial Virus (RSV)

1.3.5 Tuberculosis

1.3.6 Streptococcus Testing

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Respiratory Disease Diagnostics Market Perspective (2020-2031)

2.2 Global Infectious Respiratory Disease Diagnostics Growth Trends by Region

2.2.1 Global Infectious Respiratory Disease Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Infectious Respiratory Disease Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Infectious Respiratory Disease Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Infectious Respiratory Disease Diagnostics Market Dynamics

2.3.1 Infectious Respiratory Disease Diagnostics Industry Trends

2.3.2 Infectious Respiratory Disease Diagnostics Market Drivers

2.3.3 Infectious Respiratory Disease Diagnostics Market Challenges

2.3.4 Infectious Respiratory Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infectious Respiratory Disease Diagnostics Players by Revenue

3.1.1 Global Top Infectious Respiratory Disease Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Infectious Respiratory Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Infectious Respiratory Disease Diagnostics Revenue

3.4 Global Infectious Respiratory Disease Diagnostics Market Concentration Ratio

3.4.1 Global Infectious Respiratory Disease Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Respiratory Disease Diagnostics Revenue in 2024

3.5 Global Key Players of Infectious Respiratory Disease Diagnostics Head office and Area Served

3.6 Global Key Players of Infectious Respiratory Disease Diagnostics, Product and Application

3.7 Global Key Players of Infectious Respiratory Disease Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Respiratory Disease Diagnostics Breakdown Data by Type

4.1 Global Infectious Respiratory Disease Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Infectious Respiratory Disease Diagnostics Forecasted Market Size by Type (2026-2031)

5 Infectious Respiratory Disease Diagnostics Breakdown Data by Application

5.1 Global Infectious Respiratory Disease Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Infectious Respiratory Disease Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Infectious Respiratory Disease Diagnostics Market Size (2020-2031)

6.2 North America Infectious Respiratory Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025)

6.4 North America Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infectious Respiratory Disease Diagnostics Market Size (2020-2031)

7.2 Europe Infectious Respiratory Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025)

7.4 Europe Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Infectious Respiratory Disease Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Infectious Respiratory Disease Diagnostics Market Size (2020-2031)

9.2 Latin America Infectious Respiratory Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Infectious Respiratory Disease Diagnostics Introduction

11.1.4 Abbott Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Thermo Fisher Scientific, Inc.

11.2.1 Thermo Fisher Scientific, Inc. Company Details

11.2.2 Thermo Fisher Scientific, Inc. Business Overview

11.2.3 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Introduction

11.2.4 Thermo Fisher Scientific, Inc. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.2.5 Thermo Fisher Scientific, Inc. Recent Development

11.3 Koninklijke Philips N.V.

11.3.1 Koninklijke Philips N.V. Company Details

11.3.2 Koninklijke Philips N.V. Business Overview

11.3.3 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Introduction

11.3.4 Koninklijke Philips N.V. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.3.5 Koninklijke Philips N.V. Recent Development

11.4 F. Hoffmann-La Roche Ltd.

11.4.1 F. Hoffmann-La Roche Ltd. Company Details

11.4.2 F. Hoffmann-La Roche Ltd. Business Overview

11.4.3 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Introduction

11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.4.5 F. Hoffmann-La Roche Ltd. Recent Development

11.5 BioMerieux SA

11.5.1 BioMerieux SA Company Details

11.5.2 BioMerieux SA Business Overview

11.5.3 BioMerieux SA Infectious Respiratory Disease Diagnostics Introduction

11.5.4 BioMerieux SA Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.5.5 BioMerieux SA Recent Development

11.6 Bio-Rad Laboratories, Inc.

11.6.1 Bio-Rad Laboratories, Inc. Company Details

11.6.2 Bio-Rad Laboratories, Inc. Business Overview

11.6.3 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Introduction

11.6.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.6.5 Bio-Rad Laboratories, Inc. Recent Development

11.7 Quidel Corporation

11.7.1 Quidel Corporation Company Details

11.7.2 Quidel Corporation Business Overview

11.7.3 Quidel Corporation Infectious Respiratory Disease Diagnostics Introduction

11.7.4 Quidel Corporation Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.7.5 Quidel Corporation Recent Development

11.8 Siemens Healthcare GmbH

11.8.1 Siemens Healthcare GmbH Company Details

11.8.2 Siemens Healthcare GmbH Business Overview

11.8.3 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Introduction

11.8.4 Siemens Healthcare GmbH Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.8.5 Siemens Healthcare GmbH Recent Development

11.9 Danaher

11.9.1 Danaher Company Details

11.9.2 Danaher Business Overview

11.9.3 Danaher Infectious Respiratory Disease Diagnostics Introduction

11.9.4 Danaher Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.9.5 Danaher Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Details

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Infectious Respiratory Disease Diagnostics Introduction

11.10.4 Qiagen Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025)

11.10.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Thermo Fisher Scientific Inc

Koninklijke Philips N V

F Hoffmann La Roche Ltd

BioMerieux SA

Bio-Rad Laboratories Inc

Quidel Corporation

Siemens Healthcare GmbH

Danaher

Qiagen NV

List of Tables

Table 1. Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Instruments

Table 3. Key Players of Consumables

Table 4. Key Players of Services

Table 5. Global Infectious Respiratory Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Infectious Respiratory Disease Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Infectious Respiratory Disease Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Infectious Respiratory Disease Diagnostics Market Share by Region (2020-2025)

Table 9. Global Infectious Respiratory Disease Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Infectious Respiratory Disease Diagnostics Market Share by Region (2026-2031)

Table 11. Infectious Respiratory Disease Diagnostics Market Trends

Table 12. Infectious Respiratory Disease Diagnostics Market Drivers

Table 13. Infectious Respiratory Disease Diagnostics Market Challenges

Table 14. Infectious Respiratory Disease Diagnostics Market Restraints

Table 15. Global Infectious Respiratory Disease Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Infectious Respiratory Disease Diagnostics Market Share by Players (2020-2025)

Table 17. Global Top Infectious Respiratory Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Respiratory Disease Diagnostics as of 2024)

Table 18. Ranking of Global Top Infectious Respiratory Disease Diagnostics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Infectious Respiratory Disease Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Infectious Respiratory Disease Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Infectious Respiratory Disease Diagnostics, Product and Application

Table 22. Global Key Players of Infectious Respiratory Disease Diagnostics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Infectious Respiratory Disease Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Type (2020-2025)

Table 26. Global Infectious Respiratory Disease Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Type (2026-2031)

Table 28. Global Infectious Respiratory Disease Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Application (2020-2025)

Table 30. Global Infectious Respiratory Disease Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Application (2026-2031)

Table 32. North America Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abbott Company Details

Table 48. Abbott Business Overview

Table 49. Abbott Infectious Respiratory Disease Diagnostics Product

Table 50. Abbott Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 51. Abbott Recent Development

Table 52. Thermo Fisher Scientific, Inc. Company Details

Table 53. Thermo Fisher Scientific, Inc. Business Overview

Table 54. Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Product

Table 55. Thermo Fisher Scientific, Inc. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Scientific, Inc. Recent Development

Table 57. Koninklijke Philips N.V. Company Details

Table 58. Koninklijke Philips N.V. Business Overview

Table 59. Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Product

Table 60. Koninklijke Philips N.V. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 61. Koninklijke Philips N.V. Recent Development

Table 62. F. Hoffmann-La Roche Ltd. Company Details

Table 63. F. Hoffmann-La Roche Ltd. Business Overview

Table 64. F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Product

Table 65. F. Hoffmann-La Roche Ltd. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 66. F. Hoffmann-La Roche Ltd. Recent Development

Table 67. BioMerieux SA Company Details

Table 68. BioMerieux SA Business Overview

Table 69. BioMerieux SA Infectious Respiratory Disease Diagnostics Product

Table 70. BioMerieux SA Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 71. BioMerieux SA Recent Development

Table 72. Bio-Rad Laboratories, Inc. Company Details

Table 73. Bio-Rad Laboratories, Inc. Business Overview

Table 74. Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Product

Table 75. Bio-Rad Laboratories, Inc. Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Bio-Rad Laboratories, Inc. Recent Development

Table 77. Quidel Corporation Company Details

Table 78. Quidel Corporation Business Overview

Table 79. Quidel Corporation Infectious Respiratory Disease Diagnostics Product

Table 80. Quidel Corporation Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 81. Quidel Corporation Recent Development

Table 82. Siemens Healthcare GmbH Company Details

Table 83. Siemens Healthcare GmbH Business Overview

Table 84. Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Product

Table 85. Siemens Healthcare GmbH Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 86. Siemens Healthcare GmbH Recent Development

Table 87. Danaher Company Details

Table 88. Danaher Business Overview

Table 89. Danaher Infectious Respiratory Disease Diagnostics Product

Table 90. Danaher Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 91. Danaher Recent Development

Table 92. Qiagen Company Details

Table 93. Qiagen Business Overview

Table 94. Qiagen Infectious Respiratory Disease Diagnostics Product

Table 95. Qiagen Revenue in Infectious Respiratory Disease Diagnostics Business (2020-2025) & (US$ Million)

Table 96. Qiagen Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Infectious Respiratory Disease Diagnostics Picture

Figure 2. Global Infectious Respiratory Disease Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Infectious Respiratory Disease Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Instruments Features

Figure 5. Consumables Features

Figure 6. Services Features

Figure 7. Global Infectious Respiratory Disease Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Infectious Respiratory Disease Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. COVID-19 Case Studies

Figure 10. Influenza Case Studies

Figure 11. Respiratory Syncytial Virus (RSV) Case Studies

Figure 12. Tuberculosis Case Studies

Figure 13. Streptococcus Testing Case Studies

Figure 14. Infectious Respiratory Disease Diagnostics Report Years Considered

Figure 15. Global Infectious Respiratory Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Infectious Respiratory Disease Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Infectious Respiratory Disease Diagnostics Market Share by Region: 2024 VS 2031

Figure 18. Global Infectious Respiratory Disease Diagnostics Market Share by Players in 2024

Figure 19. Global Top Infectious Respiratory Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Respiratory Disease Diagnostics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Infectious Respiratory Disease Diagnostics Revenue in 2024

Figure 21. North America Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Infectious Respiratory Disease Diagnostics Market Share by Country (2020-2031)

Figure 23. United States Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Infectious Respiratory Disease Diagnostics Market Share by Country (2020-2031)

Figure 27. Germany Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Infectious Respiratory Disease Diagnostics Market Share by Region (2020-2031)

Figure 35. China Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Infectious Respiratory Disease Diagnostics Market Share by Country (2020-2031)

Figure 43. Mexico Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Share by Country (2020-2031)

Figure 47. Turkey Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Infectious Respiratory Disease Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbott Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 51. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 52. Koninklijke Philips N.V. Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 53. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 54. BioMerieux SA Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 55. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 56. Quidel Corporation Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 57. Siemens Healthcare GmbH Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 58. Danaher Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 59. Qiagen Revenue Growth Rate in Infectious Respiratory Disease Diagnostics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Respiratory Diagnostic Devices Market Research Report 2024

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Rapid Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024

Global Anti infectious Disease Drugs Market Research Report 2025

Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Infection Diagnostic Market Research Report 2024

Upper Respiratory Tract Disorder Diagnostics and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Antiviral Treatment Market Research Report 2024

Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Rapid Diagnostic Testing Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rhinovirus Infections Drug Market Research Report 2024

Global Inhaled Anti Infectives Market Research Report 2025

Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024

Respiratory Syncytial Virus RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotic Resistance Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Digestive System Antacids Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24T19051

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Hemostats For Wound Closure Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19K19445

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Renal Denervation (RDN) Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17S14385

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Cholesterol HP Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17C19514

Wed May 21 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions